What does VMAT2 do?

Table of Contents

The vesicular monoamine transporter 2 (VMAT2) is an integral presynaptic protein that regulates the packaging and subsequent release of dopamine and other monoamines from neuronal vesicles into the synapse.

What blocks VMAT?

By acting as a competitive antagonist, methamphetamine blocks the presynaptic cell’s ability to use VMAT for vesicular packaging.

What is the VMAT2 gene?

The God gene hypothesis proposes that human spirituality is influenced by heredity and that a specific gene, called vesicular monoamine transporter 2 (VMAT2), predisposes humans towards spiritual or mystic experiences.

What are VMAT2 inhibitors?

The vesicular monoamine transporter type 2 (VMAT2) inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases (such as Huntington chorea) or dyskinesias due to neuroleptic medications (tardive dyskinesia).

Where is VMAT2 located?

adrenal medulla
VMAT2 is primarily expressed in multiple monoaminergic cells in the brain, sympathetic nervous system, mast cells, and histamine containing cells in the gut19–20. VMAT1 and VMAT2 are co-expressed in chromaffin cells of the adrenal medulla.

What do dopamine transporters do?

The dopamine transporter (also dopamine active transporter, DAT, SLC6A3) is a membrane-spanning protein that pumps the neurotransmitter dopamine out of the synaptic cleft back into cytosol. In the cytosol, other transporters sequester the dopamine into vesicles for storage and later release.

Where is VMAT2 located in the brain?

The major finding from a practical neuroimaging perspective is that the levels of VMAT2 protein in the cerebellar cortex and the widespread cerebral neocortical areas were all at least 100-fold lower than those in striatum.

What do serotonin transporters do?

Function. The serotonin transporter removes serotonin from the synaptic cleft back into the synaptic boutons. Thus, it terminates the effects of serotonin and simultaneously enables its reuse by the presynaptic neuron. Neurons communicate by using chemical messengers like serotonin between cells.

How do VMAT2 inhibitors work?

VMAT2 inhibitors block VMAT2 causing dopamine depletion in the central nervous system. VMAT2 is a protein that controls the amount of dopamine stored in the nerve cells and the amount released. Inhibiting VMAT2 leads to a lower amount of available dopamine, thereby reducing unwanted body movements.

What is SLC18A2 gene?

SLC18A2 Gene – Solute Carrier Family 18 Member A2 This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles.

What is VMAT in pharmacology?

Vesicular monoamine transporters (VMAT) are responsible for the uptake of cytosolic monoamines into synaptic vesicles in monoaminergic neurons. Two closely related VMATs with distinct pharmacological properties and tissue distributions have been characterized.

What happens if you block dopamine transporters?

The rate at which DAT removes dopamine from the synapse can have a profound effect on the amount of dopamine in the cell. This is best evidenced by the severe cognitive deficits, motor abnormalities, and hyperactivity of mice with no dopamine transporters.

How does the serotonin transporter gene cause depression?

The serotonin transporter gene has received the most attention in relation to depression, either alone or in conjunction with exposure to stressful life events (i.e. a gene x environment interaction), whereas neuroimaging studies have suggested an association with amygdala activation.

Is low serotonin genetic?

Clinicians have long theorized that serotonin levels are genetically low in some people with depression, so this study undermines that theory. Numerous ailments can cause symptoms of serotonin deficiency, so it’s important to see a health care provider to get an accurate diagnosis and appropriate treatment.

What is Vmat in pharmacology?

What is vesicular monoamine transporter VMAT2?

The vesicular monoamine transporter VMAT2, is a proton-dependent transporter that sequesters monoamine neurotransmitters from free cytoplasmic space into synaptic vesicles (Miller et al. 1999a).

What does VMAT2 stand for?

What are VMAT2 inhibitors used to treat?

VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors) are used to treat movement disorders such as Huntington’s disease or tardive dyskinesia. In Huntington’s disease the uncontrollable movements may start out mild as fidgeting or quick movements of the feet and hands and then, as the disease progresses,…

How is VMAT2 different from other neurotransmitter transporters?

In this way, the VMAT2 is distinct from the plasma membrane neurotransmitter transporters (dopamine [DAT], serotonin [SERT], and norepinephrine [NET]), which selectively move only 1 of the neurotransmitters from the synapse into the cell.